SUMMARY Pulmonary fat embolism in a preterm infant receiving Intralipid intravenously is described. Serum obtained at the time of clinical deterioration agglutinated Intralipid. This coincided with the onset of septicaemia and with a raised serum C reactive protein concentration. Subsequent clinical improvement was associated with reduction in the C reactive protein concentration and nonagglutination of Intralipid.
Intravenous infusion of Intralipid (Kabi-vitrum) has been widely used as a calorie rich supplement and a source of essential fatty acids in intravenous feeding regimens for neonates.' Fat embolism, however, has been found at necropsy in the lungs of infants who have died while receiving intravenous Intralipid.2 3 Hulman et a14 noted that serum of ill adult patients with a raised concentration of C reactive protein agglutinated Intralipid in vitro and have suggested that this is the mechanism for lipid microembolisation in vivo.
Case history
A boy weighing 800 g was born vaginally at 26 weeks' gestation. He developed hyaline membrane disease requiring intermittent positive pressure ventilation and thereafter required prolonged mechanical assistance for apnoea. The infant was fed parenterally via peripheral veins using a mixture of 10% Intralipid; Vamin-Glucose (Kabi-vitrum); and 10% dextrose with electrolyte, trace metal, and vitamin additives. Intralipid was administered by continuous infusion over 20 hours using a syringe pump. Fat intake was initially started at 0-5 g/kg/day and subsequently increased to a maximum of 4 g/kg/day. Serum was examined visually four hours after stopping Intralipid infusion to confirm clearance of Intralipid.
While on continuous positive airways pressure on day 41, the infant's general condition deteriorated; there was temperature instability and an increase in oxygen requirement for which intermittent positive pressure ventilation was instituted. At the time, fat globules were identified in a tracheal aspirate on Sudan III staining. Pulmonary lipid microembolisation was suspected and intravenous feeding was stopped. Naso-jejunal feeds were introduced cautiously after 48 hours. Blood cultures taken at the time of the deterioration grew Candida albicans and treatment with intravenous amphoteracin and miconazole was begun. There was rapid improvement in the child's respiratory status, with reduction in both the oxygen requirement and the need for ventilatory support, and by day 49 he was extubated into an oxygen enriched environment.
Blood was drawn on days 14, 41, 45, 48, and 54 of life. The serum concentration of C reactive protein was assessed using rocket immunoelectrophoresis technique. Postnatal age (days ) was at the maximum value of 150 mg/l caused in vitro agglutination of Intralipid. On day 14 before the episode of presumed sepsis and on day 54 after its successful treatment, the concentrations were low (2 mg/l and 7 mg/I, respectively). On neither of these occasions did in vitro agglutination of Intralipid occur. The infant was discharged on day 114.
Discussion
In this infant an increase in oxygen requirement necessitating ventilatory support coincided with the presence of fat globules in the tracheal aspirate. In their account of post-traumatic fat embolism in children Weisz et al6 include fat excretion in sputum and hypoxia among the diagnostic signs, and we suggest that pulmonary fat embolism contributed to the observed clinical deterioration of our patient.
Sabel et a! have found a raised serum C reactive protein concentration to be a useful indication of neonatal sepsis. The C reactive protein value in our patient rose at the onset of candida septicaemia and fell to a normal value (0 to 10 mg/i) after specific parenteral antifungal treatment was begun. In vitro agglutination of Intralipid was observed when the C reactive protein concentration was at its peak and this coincided with the clinical suspicion of pulmonary fat embolism. In vitro agglutination of Intralipid was not observed when the concentrations were low, that is before onset of septicaemia and after successful treatment. Those infants previously described,2 3 with necropsy evidence of pulmonary fat embolism had all been very ill; many, as in this patient, with septicaemia. Although Intralipid has been of undoubted value in the management of sick neonates we believe our observations support the view of Hulman et 
